A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Aripiprazole Impurity 26 - Request Quote

Picture of Aripiprazole Impurity 26

Aripiprazole Impurity 26

SZ CAT No:SZ-A001052
CAS No
NA
Mol.F.
C18H16N2O4
Mol.Wt.
324.3
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Aripiprazole Impurity 26 is chemically N-(3-Hydroxyphenyl)-3-((2-oxo-1,2-dihydroquinolin-7-yl)oxy)propanamide. Aripiprazole Impurity 26 is supplied with detailed characterization data compliant with regulatory guideline. Aripiprazole Impurity 26 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Aripiprazole.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Aripiprazole Impurity 26

Purchase Aripiprazole Impurity 26

Aripiprazole Impurity 26 suppliers

Aripiprazole Impurity 26 manufacturers

Aripiprazole Impurity 26 price

Order Aripiprazole Impurity 26

Enquire Aripiprazole Impurity 26

Aripiprazole Impurity 26 cost

Aripiprazole Impurity 26 Supplier

Aripiprazole Impurity 26 Distributor

Aripiprazole Impurity 26 for Method Validation

Aripiprazole Reference Standard

Aripiprazole Impurity 26 for ANDA Filing

Aripiprazole Impurity 26 for Forced Degradation Studies

Aripiprazole Impurity 26 Identification Standards

Aripiprazole Impurity 26 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,